News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more.
A court in San Diego has stated that part of the suit between Quidel and Beckman is void as a matter of law.
The high-sensitivity test runs on the Quidel Triage Meter Pro instrument and joins a growing list of similar tests that have recently received regulatory approvals.
1Drop anticipates the platform will be capable of handling up to 64 clinical biomarkers, including indicators of cardiovascular diseases and many others.
The companies plan to enable at-home testing by integrating Siemens Healthineers' urinalysis reagents into Healthy.io’s smartphone-based urinalysis system.
The company is developing point-of-care tests for monitoring kidney function (penKid) and endothelial dysfunction in patients at risk of heart failure.
